These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 25270629

  • 1. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke.
    Urfer R, Moebius HJ, Skoloudik D, Santamarina E, Sato W, Mita S, Muir KW, Cutamesine Stroke Recovery Study Group.
    Stroke; 2014 Nov; 45(11):3304-10. PubMed ID: 25270629
    [Abstract] [Full Text] [Related]

  • 2. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z, Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators.
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [Abstract] [Full Text] [Related]

  • 3. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
    Chen CL, Young SH, Gan HH, Singh R, Lao AY, Baroque AC, Chang HM, Hiyadan JH, Chua CL, Advincula JM, Muengtaweepongsa S, Chan BP, de Silva HA, Towanabut S, Suwanwela NC, Poungvarin N, Chankrachang S, Wong KS, Eow GB, Navarro JC, Venketasubramanian N, Lee CF, Bousser MG, CHIMES Study Investigators.
    Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
    [Abstract] [Full Text] [Related]

  • 4. NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.
    Nacu A, Kvistad CE, Naess H, Øygarden H, Logallo N, Assmus J, Waje-Andreassen U, Kurz KD, Neckelmann G, Thomassen L.
    Stroke; 2017 Feb; 48(2):335-341. PubMed ID: 27980128
    [Abstract] [Full Text] [Related]

  • 5. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U.
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [Abstract] [Full Text] [Related]

  • 6. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Savitz SI, Yavagal D, Rappard G, Likosky W, Rutledge N, Graffagnino C, Alderazi Y, Elder JA, Chen PR, Budzik RF, Tarrel R, Huang DY, Hinson JM.
    Circulation; 2019 Jan 08; 139(2):192-205. PubMed ID: 30586746
    [Abstract] [Full Text] [Related]

  • 7. Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic Stroke.
    Mizuma A, Yamashita T, Kono S, Nakayama T, Baba Y, Itoh S, Asakura K, Niimi Y, Asahi T, Kanemaru K, Mutoh T, Kuroda S, Kinouchi H, Abe K, Takizawa S.
    J Stroke Cerebrovasc Dis; 2016 Jun 08; 25(6):1451-7. PubMed ID: 27017282
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
    Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, Vogt G, Charissé G, Fiebach JB, Schwab S, Schäbitz WR, Kollmar R, Fisher M, Brozman M, Skoloudik D, Gruber F, Serena Leal J, Veltkamp R, Köhrmann M, Berrouschot J, AXIS 2 Investigators.
    Stroke; 2013 Oct 08; 44(10):2681-7. PubMed ID: 23963331
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
    Di Cesare F, Mancuso J, Woodward P, Bednar MM, Loudon PT, A9541004 Stroke Study Group.
    J Stroke Cerebrovasc Dis; 2016 Mar 08; 25(3):642-9. PubMed ID: 26738812
    [Abstract] [Full Text] [Related]

  • 10. Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
    Siebler M, Hennerici MG, Schneider D, von Reutern GM, Seitz RJ, Röther J, Witte OW, Hamann G, Junghans U, Villringer A, Fiebach JB.
    Stroke; 2011 Sep 08; 42(9):2388-92. PubMed ID: 21852609
    [Abstract] [Full Text] [Related]

  • 11. Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
    Kraglund KL, Mortensen JK, Damsbo AG, Modrau B, Simonsen SA, Iversen HK, Madsen M, Grove EL, Johnsen SP, Andersen G.
    Stroke; 2018 Nov 08; 49(11):2568-2576. PubMed ID: 30355209
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
    Levy ML, Crawford JR, Dib N, Verkh L, Tankovich N, Cramer SC.
    Stroke; 2019 Oct 08; 50(10):2835-2841. PubMed ID: 31495331
    [Abstract] [Full Text] [Related]

  • 13. RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke.
    England TJ, Hedstrom A, O'Sullivan S, Donnelly R, Barrett DA, Sarmad S, Sprigg N, Bath PM.
    Stroke; 2017 May 08; 48(5):1412-1415. PubMed ID: 28265014
    [Abstract] [Full Text] [Related]

  • 14. CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke.
    Barreto AD, Alexandrov AV, Shen L, Sisson A, Bursaw AW, Sahota P, Peng H, Ardjomand-Hessabi M, Pandurengan R, Rahbar MH, Barlinn K, Indupuru H, Gonzales NR, Savitz SI, Grotta JC.
    Stroke; 2013 Dec 08; 44(12):3376-81. PubMed ID: 24159060
    [Abstract] [Full Text] [Related]

  • 15. Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin).
    Montaner J, Bustamante A, García-Matas S, Martínez-Zabaleta M, Jiménez C, de la Torre J, Rubio FR, Segura T, Masjuán J, Cánovas D, Freijo M, Delgado-Mederos R, Tejada J, Lago A, Bravo Y, Corbeto N, Giralt D, Vives-Pastor B, de Arce A, Moniche F, Delgado P, Ribó M, STARS Investigators.
    Stroke; 2016 Nov 08; 47(11):2870-2873. PubMed ID: 27758944
    [Abstract] [Full Text] [Related]

  • 16. Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage.
    Shimazawa M, Sugitani S, Inoue Y, Tsuruma K, Hara H.
    Exp Eye Res; 2015 Mar 08; 132():64-72. PubMed ID: 25616094
    [Abstract] [Full Text] [Related]

  • 17. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial.
    England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, Walker M, Bath PM.
    Stroke; 2012 Feb 08; 43(2):405-11. PubMed ID: 22198983
    [Abstract] [Full Text] [Related]

  • 18. Activation of Sigma-1 Receptor by Cutamesine Attenuates Neuronal Apoptosis by Inhibiting Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in a Rat Model of Asphyxia Cardiac Arrest.
    Qin J, Wang P, Li Y, Yao L, Liu Y, Yu T, Lin J, Fang X, Huang Z.
    Shock; 2019 Jan 08; 51(1):105-113. PubMed ID: 29424796
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Elkins J, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K, Lansberg MG, Tang W, Chang I, Muralidharan K, Gheuens S, Mehta L, Elkind MSV.
    Lancet Neurol; 2017 Mar 08; 16(3):217-226. PubMed ID: 28229893
    [Abstract] [Full Text] [Related]

  • 20. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS, Rikhtegar R, Hashemilar M, Sadeghi-Bazargani H, Sharifi-Bonab M, Sadeghi-Hokmabadi E, Zarrintan S, Sharifipour E.
    J Stroke Cerebrovasc Dis; 2013 Nov 08; 22(8):e557-63. PubMed ID: 23871729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.